Ratings by TD Cowen (Steve Scala)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Royalty Pharma | RPRX | Maintain | (N/A) |
|
Details | ||
| 6/30/2026 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2026 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2026 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Molecular Partners | MOLN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | Novartis | NVS | Maintain | Hold (N/A) |
|
Details | ||
| 2/9/2026 | GlaxoSmithKline | GSK | Maintain | Hold (N/A) |
|
Details | ||
| 2/5/2026 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2026 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 12/30/2025 | Sanofi | SNY | Maintain | Hold (N/A) |
|
Details | ||
| 12/30/2025 | Pfizer | PFE | Maintain | Hold (N/A) |
|
Details | ||
| 12/11/2025 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2025 | Novartis | NVS | Maintain | Hold (N/A) |
|
Details | ||
| 11/10/2025 | Novartis | NVS | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2025 | Pfizer | PFE | Maintain | Hold (N/A) |
|
Details | ||
| 9/12/2025 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2025 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 6/5/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Sanofi | SNY | Maintain | Hold (N/A) |
|
Details | ||
| 5/21/2025 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2025 | Pfizer | PFE | Maintain | Hold (N/A) |
|
Details | ||
| 4/22/2025 | Organon & Co. | OGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/22/2025 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2025 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Merck | MRK | Downgrade | Hold (Buy) |
87.28 (152.20) |
74.38% | Details | |
| 12/18/2024 | Sanofi-Aventis | SNY | Maintain | Hold (N/A) |
|
Details | ||
| 12/10/2024 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 10/7/2024 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Novartis | NVS | Maintain | Hold (N/A) |
|
Details | ||
| 10/7/2024 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Pfizer | PFE | Maintain | Hold (N/A) |
|
Details | ||
| 10/7/2024 | Organon & Co. | OGN | Maintain | Hold (N/A) |
|
Details | ||
| 9/6/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 8/12/2024 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2024 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2024 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2024 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 5/14/2024 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Merck | MRK | Upgrade | Buy (Hold) |
114.77 (87.28) |
-23.95% | Details | |
| 1/4/2024 | Pfizer | PFE | Downgrade | Hold (Buy) |
29.73 (28.24) |
-5.01% | Details | |
| 9/26/2023 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 9/15/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2023 | Roche | RHHBY | Maintain | Hold (N/A) |
|
Details | ||
| 5/23/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 12/5/2022 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Roche | RHHBY | Downgrade | Hold (Buy) |
43.25 (58.20) |
34.57% | Details | |
| 9/12/2022 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2022 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 6/27/2022 | Roche | RHHBY | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2022 | EQRx, Inc. | EQRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2022 | EQRx, Inc. | EQRX | New Coverage | Buy (N/A) |
4.42 (2.34) |
-47.06% | Details | |
| 4/14/2022 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2021 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2021 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2021 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2021 | Organon & Co. | OGN | New Coverage | Hold (N/A) |
8.00 (15.66) |
95.75% | Details | |
| 3/18/2021 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2021 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2021 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2021 | Novartis | NVS | Downgrade | Hold (Buy) |
90.47 (160.31) |
77.2% | Details | |
| 12/10/2020 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2020 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2020 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | Royalty Pharma | RPRX | New Coverage | Buy (N/A) |
47.64 (61.73) |
29.58% | Details | |
| 6/30/2020 | Merck | MRK | Maintain | Hold (N/A) |
|
Details | ||
| 6/29/2020 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 6/18/2020 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2020 | AstraZeneca | AZN | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2020 | Novartis | NVS | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2019 | Sanofi-Aventis | SNY | Maintain | Hold (N/A) |
|
Details | ||
| 12/2/2019 | AstraZeneca | AZN | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 11/12/2019 | Roche | RHHBY | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2019 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 5/21/2019 | Novartis | NVS | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2019 | AstraZeneca | AZN | Upgrade | Buy (Hold) |
42.98 (92.77) |
115.84% | Details | |
| 2/13/2019 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2018 | Novartis | NVS | Upgrade | Buy (Hold) |
89.03 (90.47) |
1.62% | Details | |
| 10/15/2018 | Elanco Animal Health | ELAN | New Coverage | Buy (N/A) |
32.39 (24.50) |
-24.36% | Details | |
| 9/6/2018 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2018 | Roche | RHHBY | Maintain | Buy (N/A) |
|
Details |
